Logo of Middle East Pharmaceutical Industries Co. (Avalon Pharma)
Middle East Pharmaceutical Industries Co. (Avalon Pharma) offered today, Jan. 30, as many as 600,000 shares for retail subscription at SAR 82 a share, as per the book-building process.
The company planned to offer six million shares, or 30% of its post-IPO capital of SAR 200 million (20 million shares).
The receiving banks are Saudi National Bank (SNB) and Alinma Bank.
Be the first to comment
Comments Analysis: